Oramed Granted NASH Patent in Europe

NEW YORK , April 5, 2022 /PRNewswire/ –  Oramed Pharmaceuticals Inc. (Nasdaq/TASE: ORMP), a clinical-stage pharmaceutical company focused on the development of oral drug delivery platforms, today announced that the European Patent Office has granted the Company the patent titled “Methods and

Join our mailing list

Skip to content